BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

TxCell 



Nice      France
Phone: n/a Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At The 16th Biotechnology Industry Organization (BIO) CEO & Investor Conference 2014, New York, U.S.A. 2/5/2014 7:41:33 AM    More...
TxCell To Present An Innovative, Personalized Cell-Based Immunotherapy Approach At Biotech Showcase™ 2014, San Francisco, USA 1/10/2014 3:43:07 PM    More...
TxCell Enters Col-Treg Into Full Development For The Rare Disease Autoimmune Uveitis 1/7/2014 12:07:26 PM    More...
TxCell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 12/3/2013 9:16:52 AM    More...
TxCell Announces Publication of CATS1 Study Results for Antigen-Specific Treg Therapy in Crohn's Disease in Gastroenterology 10/24/2012 11:03:54 AM    More...
TxCell Presents Immuno-Monitoring Results of Its Phase I/II Clinical Trial With Antigen-Specific Treg Cells in Crohn's Disease 2/21/2012 9:42:18 AM    More...
TxCell Presents Final Positive Results of the Phase I/II Clinical Trial With Antigen-Specific Treg Cells in Crohn's Disease 10/25/2011 10:20:40 AM    More...
TxCell Receives Approval for Extension of Phase I/II Clinical Trial in Crohn's Disease 5/18/2011 12:29:22 PM    More...
TxCell Receives Approval for a Phase I/II Clinical Trial in Rheumatoid Arthritis 4/4/2011 9:43:46 AM    More...
TxCell Names Francois Meyer as CEO 3/9/2011 7:20:50 AM    More...
12